Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

GMALL 08/2013 - ALL/LBL consolidation I (day 60), 18 - 55 years, all risk groups

Protocol-ID: 595 V3.0 (Mini), GMALL 08/2013-ALL/LBL Consolidation I (d60), 18 - 55, all risk groups
Study protocol, available to authorized participants only.

Indication(s)

  • Acute Lymphoblastic Leukaemia; ICD-10 C91.0-
  • NHL, B-Cell Type, Lymphoblastic Lymphoma; ICD-10 C83.5
  • NHL, T-Cell Type, Lymphoblastic Lymphoma; ICD-10 C83.5

Links

  • Studie GMALL08_2013, Treatment Optimization in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment - a Phase IV-trial With a Phase III-part to Evaluate Safety and Efficacy of Nelarabine in T-ALL Patients [clinicaltrials.gov]
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 24.01.2023